Abstract:Inflammasomes are supramolecular platforms that organize in response to various damage-associated molecular patterns and pathogen-associated molecular patterns. Upon activation, inflammasome sensors (with or without the help of ASC) activate caspase-1 and other inflammatory caspases that cleave gasdermin D and pro-IL-1β/pro-IL-18, leading to pyroptosis and mature cytokine secretion. Pyroptosis enables intracellular pathogen niche disruption and intracellular content release at the cost of cell death, inducing pro-inflammatory responses in the neighboring cells. IL-1β is a potent pro-inflammatory regulator for neutrophil recruitment, macrophage activation, and T-cell expansion. Thus, pyroptosis and cytokine secretion are the two main mechanisms that occur downstream of inflammasome signaling; they maintain homeostasis, drive the innate immune response, and shape adaptive immunity. This review aims to discuss the possible mechanisms, timing, consequences, and significance of the two uncoupling preferences downstream of inflammasome signaling. While pyroptosis and cytokine secretion may be usually coupled, pyroptosis-predominant and cytokine-predominant uncoupling are also observed in a stimulus-, cell type-, or context-dependent manner, contributing to the pathogenesis and development of numerous pathological conditions such as cryopyrin-associated periodic syndromes, LPS-induced sepsis, and Salmonella enterica serovar Typhimurium infection. Hyperactive cells consistently release IL-1β without LDH leakage and pyroptotic death, thereby leading to prolonged inflammation, expanding the lifespans of pyroptosis-resistant neutrophils, and hyperactivating stimuli-challenged macrophages, dendritic cells, monocytes, and specific nonimmune cells. Death inflammasome activation also induces GSDMD-mediated pyroptosis with no IL-1β secretion, which may increase lethality in vivo . The sublytic GSDMD pore formation associated with lower expressions of pyroptotic components, GSDMD-mediated extracellular vesicles, or other GSDMD-independent pathways that involve unconventional secretion could contribute to the cytokine-predominant uncoupling; the regulation of caspase-1 dynamics, which may generate various active species with different activities in terms of GSDMD or pro-IL-1β, could lead to pyroptosis-predominant uncoupling. These uncoupling preferences enable precise reactions to different stimuli of different intensities under specific conditions at the single-cell level, promoting cooperative cell and host fate decisions and participating in the pathogen "game". Appropriate decisions in terms of coupling and uncoupling are required to heal tissues and eliminate threats, and further studies exploring the inflammasome tilt toward pyroptosis or cytokine secretion may be helpful.

Ubiquitination is a Major Modulator for the Activation of Inflammasomes and Pyroptosis

Regulation of the Inflammasome Activation by Ubiquitination Machinery

Activation and Pharmacological Regulation of Inflammasomes

A bacterial phospholipid phosphatase inhibits host pyroptosis by hijacking ubiquitin

Molecular mechanism of pyroptosis and inflammasome activation

Ubiquitination in the regulation of inflammatory cell death and cancer

Ubiquitination in pyroptosis pathway: A potential therapeutic target for sepsis

Progress on Activation and Regulation of Inflammasomes

Post-translational control of NLRP3 inflammasome signaling

Ubiquitination Regulation of Inflammatory Responses Through NF-κB Pathway.

Unanchored ubiquitin chains promote the non-canonical inflammasome via UBXN1

Control of Inflammasome Activation by Phosphorylation

Post-translational Regulation of Inflammasomes

Emerging Insights into Molecular Mechanisms Underlying Pyroptosis and Functions of Inflammasomes in Diseases

Molecular mechanisms of emerging inflammasome complexes and their activation and signaling in inflammation and pyroptosis

Research Progress of the Relationship Between Pyroptosis and Disease

Advance in Research on the Regulation of Innate Immune Response by Ubiquitination

Inflammasomes as therapeutic targets in human diseases

Uncoupled pyroptosis and IL-1β secretion downstream of inflammasome signaling

Inflammasomes: mechanism of action, role in disease, and therapeutics

The advances in pyroptosis initiated by inflammasome in inflammatory and immune diseases